Table 2 Long-term manifestations of COVID-19 reported by MS patients
From: Multiple sclerosis patients’ response to COVID-19 pandemic and vaccination in Egypt
Symptom | n | % |
|---|---|---|
No long-term manifestations | 24 | 74.4 |
Sleep abnormalities | 5 | 12.8 |
Headache | 5 | 12.8 |
Chronic fatigue | 3 | 7.7 |
Depression, anxiety | 1 | 2.6 |
Vertigo | 1 | 2.6 |
Anosmia | 0 | 0.0 |
Peripheral neuropathy or myopathy | 0 | 0.0 |